It may be that an anti-immune mechanism exists in RCC that efficiently protects cancer cells from CD8+ cytotoxic T cells, although the immune system reacts by recruiting elevated numbers of lymphocytes that are also capable of intratumoral expansion. This evidence concerns the gene CD8A and renal cell adenocarcinoma.